Literature DB >> 28692838

Low ADAMTS13 levels are associated with venous thrombosis risk in women.

D Llobet1, I Tirado2, N Vilalta2, C Vallvé2, A Oliver3, M Vázquez-Santiago2, J Mateo2, J Millón2, J Fontcuberta2, J C Souto2.   

Abstract

Entities:  

Keywords:  ABO blood groups; ADAMTS13; Thrombosis; von Willebrand factor

Mesh：

Substances：

Year:  2017        PMID： 28692838     DOI： 10.1016/j.thromres.2017.07.001

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  3 in total

1.  Double positivity of anti-β2-glycoprotein I domain I and anti-phosphatidylserine/prothrombin antibodies enhances both thrombosis and positivity of anti-ADAMTS13 antibody.

Authors:  Jiwon Yun; JaYoon Gu; Hyun Kyung Kim
Journal:  J Thromb Thrombolysis       Date:  2021-04-29       Impact factor: 2.300

2.  The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension.

Authors:  Michael Newnham; Kieron South; Marta Bleda; William R Auger; Joan A Barberà; Harm Bogaard; Katherine Bunclark; John E Cannon; Marion Delcroix; Charaka Hadinnapola; Luke S Howard; David Jenkins; Eckhard Mayer; Choo Ng; Christopher J Rhodes; Nicholas Screaton; Karen Sheares; Michael A Simpson; Mark Southwood; Li Su; Dolores Taboada; Matthew Traylor; Richard C Trembath; Sofia S Villar; Martin R Wilkins; John Wharton; Stefan Gräf; Joanna Pepke-Zaba; Michael Laffan; David A Lane; Nicholas W Morrell; Mark Toshner
Journal:  Eur Respir J       Date:  2019-03-28       Impact factor: 16.671

3.  Effects of anti-β2GPI antibodies on VWF release from human umbilical vein endothelial cells and ADAMTS13 activity.

Authors:  Christopher J Ng; Keith R McCrae; Katrina Ashworth; Lucas J Sosa; Venkaiah Betapudi; Marilyn J Manco-Johnson; Alice Liu; Jing-Fei Dong; Dominic Chung; Tara C White-Adams; José A López; Jorge Di Paola
Journal:  Res Pract Thromb Haemost       Date:  2018-03-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.